Canada markets closed

Thiogenesis Therapeutics, Corp. (TTI.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.7400-0.0300 (-3.90%)
At close: 03:38PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-02-28
2021-02-28
2020-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
-
-
-
499.702
Selling General and Administrative
218.21
218.21
89.029
103.9485
Total Operating Expenses
224.678
224.678
92.653
603.6505
Operating Income or Loss
-224.678
-224.678
-92.653
-603.6505
Interest Expense
0.026
0.026
0.025
3.5054
Income Before Tax
-224.457
-224.457
-92.678
-607.36
Income from Continuing Operations
-224.457
-224.457
-92.678
-607.36
Net Income
-224.457
-224.457
-92.678
-607.36
Net Income available to common shareholders
-224.457
-224.457
-92.678
-607.36
Basic EPS
-0.01
-0.01
-0.01
-0.02
Diluted EPS
-0.01
-0.01
-0.01
-0.02
Basic Average Shares
27,910
27,910
12,000
27,910
Diluted Average Shares
27,910
27,910
12,000
27,910